Education

Managing Risk in Nuclear Medicine

Overview: This course provides the information necessary in making informed decisions in the management of          radiopharmaceuticals for patient imaging and treatment. The material addresses five key objectives: Regulation of radiopharmaceuticals as prescription drugs; The term "compounding" as it pertains to radiopharmaceuticals; Terms and acronyms used by the FDA to designate approved radiopharmaceuticals; Aspects of institutional management of radiopharmaceuticals as prescription drugs; and Risks and liabilities associated with the handling of radiopharmaceuticals.

Note: If you need the registration code for this course, contact your Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC02832

Approved for 1.0 CEH(s) Category A [California Scope: R]

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC05158

Approved for 1.0 CEH(s) Category A [California Scope: R]

USP<797> Overview

Overview: This course educates the nuclear medicine community about USP <797> and how it impacts our nuclear pharmacy and nuclear medicine practices including compounding risk levels stated by USP<797> and how they apply to radiopharmaceuticals, ISO class descriptions, and quality and safety requirements for garbing and sterile compounding.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC01782

Approved for 1.0 CEH(s) Category A [California Scope: R]

Pediatric Dosing of Radiopharmaceuticals

Overview: This program reviews concepts in radiation biology and patient dosimetry including methods to calculate pediatric doses of radiopharmaceuticals based on recommendations from the North American Consensus Guidelines and the European Association of Nuclear Medicine’s Pediatric Doses Card. Content includes explanation of the biological effects of radiation in the pediatric patient and discussion of the risk of nuclear medicine procedures in pediatric patients.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC03903

Approved for 1.0 CEH(s) Category A [California Scope: R]

Lymph Node Localization in Breast and Melanoma Patients

Overview: This course defines the clinical rational and indications for lymph node imaging studies in patients with breast cancer and melanoma; recognizes the physiology of lymphatic drainage and the relevance to injection technique; describes the technical requirements for lymph node imaging studies and considers the collaborative aspects of lymph node imaging: imaging lab and surgical team.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC03524

Approved for 1.0 CEH(s) Category A [California Scope: .50 I and .50 NI]

Radiolabeling of Autologous Leukocytes

Overview: This course will teach nuclear medicine technologists appropriate indications for leukocyte labeling, explain the procedures used in tagging WBC, identify techniques to improve labeling or troubleshoot issues during the process, discuss issues of imaging with labeled leukocytes and discuss emerging alternatives to leukocyte labeling for inflammation/infection.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC02289

Approved for 1.0 CEH(s) Category A [California Scope: .50 NI and .50R]

Radioimmunotherapy in the Treatment of Non-Hodgkin's Lymphoma

Overview: This course is designed to educate nuclear medicine technologists about the properties and protocols of the radiopharmaceuticals used in radioimmunotherapy. Also covered is a review of various treatment options for Non-Hodgkin’s Lymphoma and radiation safety procedures used to minimize contamination and exposure.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC01790

Approved for 1.0 CEH(s) Category A [California Scope: .50 R/ .50 T]

Tc-99m Radiolabeling of Red Blood Cells

Overview: This course is designed to educate nuclear medicine technologists about the different methods of radiolabeling red blood cells with Tc-99m and to explain the factors that can alter RBC labeling.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC01481

Approved for 1.0 CEH(s) Category A [California Scope: R]

Understanding the Transition from HEU to Non-HEU Radiopharmaceuticals

Overview: Participants completing this module will be able to describe the global supply chain for Tc99m; understand the security concerns relative to transitioning to non-HEU radiopharmaceuticals; show familiarity with new technologies in development for increased supply of non-HEU sources in the United States; understand the transition timeline for HEU to non-HEU alternatives and the challenges inherent in the transition; and understand basic requirements to receive CMS reimbursement for products sources from non-HEU generators.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC01784

Approved for 1.0 CEH(s) Category A [California Scope: I]

Pharmacologic Stress Agents in Myocardial Perfusion Imaging

Overview: This program offers brief reviews of the indications for stress myocardial perfusion studies, reasons for using a chemical stress agents in a patient, factors leading to the selection of the stress agent, dosing regimens, adverse effects, pharmacologic effect and expected clinical results.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma representative or email jdr.traincomm@jubl.com.

SNMMI-TS VOICE Reference Number: CEC01891

Approved for 1.0 CEH(s) Category A [California Scope: R]

Non CEU Basic Radiation Safety Course

Overview: This introductory course provides important basic safety information for individuals working in and around nuclear medicine facilities. Available exclusively to Jubilant Radiopharma customers and their employees.

Technologists: Approved by the ASRT for Category A+ continuing education credit. ASRT Reference #FLZ0054024R

The code you will need for the registration process to take this course is TriadBRS.

This course is not accredited by SNMMI or any other industry organization and carries no CEU credit. A certificate is awarded after successful completion of the course and related quiz. It is your responsibility to print out and/or download and save a copy of this certificate for your records.

Note: To access this course, you will be required to register on the MedXcel website. Click the Get Started button below.

Note: If you encounter technical issues with this course, quiz or certificate, please contact Critical Point at moreinfo@criticalpoint.com.